These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 39235792)
21. Balloon-mounting stent versus balloon angioplasty for intracranial arterial stenosis: A systematic review and meta-analysis. Musmar B; Salim H; Abdelgadir J; Spellicy S; Adeeb N; Liu J; Jabbour P; Hasan D; Zomorodi A J Stroke Cerebrovasc Dis; 2024 May; 33(5):107631. PubMed ID: 38331010 [TBL] [Abstract][Full Text] [Related]
22. Elective percutaneous intervention for intracranial atherosclerotic stenoses by interventional cardiologists. Badawi RA; White CJ; Collins TJ; Jenkins JS; Reilly JP; Grise MA; McMullan PW; Ramee SR Catheter Cardiovasc Interv; 2012 Jul; 80(1):121-7. PubMed ID: 22120976 [TBL] [Abstract][Full Text] [Related]
23. Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis. Wang T; Luo J; Wang X; Yang K; Jadhav V; Gao P; Ma Y; Zhao N; Jiao L Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013267. PubMed ID: 32789891 [TBL] [Abstract][Full Text] [Related]
24. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial. Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771 [TBL] [Abstract][Full Text] [Related]
25. Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis. Ueda T; Takaishi S; Yoshie T; Usuki N; Tatsuno K; Ohtsubo H; Araga T; Kaga Y; Takada T BMC Neurol; 2022 Dec; 22(1):477. PubMed ID: 36510182 [TBL] [Abstract][Full Text] [Related]
31. Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis. Gao P; Wang D; Zhao Z; Cai Y; Li T; Shi H; Wu W; He W; Yin L; Huang S; Zhu F; Jiao L; Ji X; Qureshi AI; Ling F AJNR Am J Neuroradiol; 2016 Jul; 37(7):1275-80. PubMed ID: 26869472 [TBL] [Abstract][Full Text] [Related]
32. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study. Gruber P; Braun C; Kahles T; Hlavica M; Anon J; Diepers M; Nedeltchev K; Berberat J; Remonda L J Neurointerv Surg; 2019 Jul; 11(7):719-722. PubMed ID: 30415229 [TBL] [Abstract][Full Text] [Related]
33. Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Jiang WJ; Du B; Leung TW; Xu XT; Jin M; Dong KH Radiology; 2007 Apr; 243(1):188-97. PubMed ID: 17392253 [TBL] [Abstract][Full Text] [Related]
34. Letter by Desai et al regarding article, "Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients". Desai SK; Murph D; Von Ritschl R Stroke; 2013 Oct; 44(10):e131. PubMed ID: 24003045 [No Abstract] [Full Text] [Related]
35. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Turan TN; Lynn MJ; Nizam A; Lane B; Egan BM; Le NA; Lopes-Virella MF; Hermayer KL; Benavente O; White CL; Brown WV; Caskey MF; Steiner MR; Vilardo N; Stufflebean A; Derdeyn CP; Fiorella D; Janis S; Chimowitz MI; Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):e51-60. PubMed ID: 22991350 [No Abstract] [Full Text] [Related]
36. Current management of symptomatic intracranial stenosis. Taylor RA; Weigele JB; Kasner SE Curr Atheroscler Rep; 2011 Aug; 13(4):321-9. PubMed ID: 21597931 [TBL] [Abstract][Full Text] [Related]
37. Challenge of identifying the cause of intracranial artery stenosis in patients with ischemic stroke. Lanthier S; Odier C; Sundararajan S; Strbian D Stroke; 2015 Mar; 46(3):e59-61. PubMed ID: 25523058 [No Abstract] [Full Text] [Related]
38. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Mazighi M; Yadav JS; Abou-Chebl A Stroke; 2008 Jun; 39(6):1766-9. PubMed ID: 18420956 [TBL] [Abstract][Full Text] [Related]
39. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries. Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445 [TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of patent foramen ovale closure versus medical therapy for prevention of recurrent ischemic neurological events: Impact of medication type. Pan X; Xu L; Zhou C; Zhang Z; Sun H Medicine (Baltimore); 2021 Jun; 100(25):e26473. PubMed ID: 34160457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]